Izokibep is a small protein molecule that acts as a selective, potent inhibitor of
interleukin 17A, to which it binds with high affinity. This study investigates izokibep in
subjects with active Hidradenitis Suppurativa (HS), including tumor necrosis factor-alpha
inhibitor (TNFi) naïve subjects, and those who had an inadequate response or intolerance to
TNFi, or for whom TNFi is contraindicated.